Add 15 common names to Jiangxi key monitoring catalogue

On July 16, Jiangxi Provincial Health and Health Commission issued the first batch of list of key controlled rational drugs in Jiangxi Province In addition to the 20 common names listed in the notice on printing and distributing the first batch of national key controlled rational drugs (chemical drugs and biological products), 15 additional common names were added: piperacillin tazobactam, human albumin, cefminol, raoxicep, violet Taxol liposome, tanshinone Ⅱ a, meroxellin sulbactam, glutathione, safflor yellow, cefotiam, lansoprazole, levofloxacin, piperacillin sulbactam Health and health committees of districts and cities, and medical institutions directly under the provincial government: now we forward the notice of the state health and Health Committee and the State Administration of traditional Chinese medicine on printing and distributing the first batch of national key monitoring and rational use of drugs (chemical and biological products) (GWB YH [2019] No 558) to you, and put forward the following requirements, please implement them together 1、 Timely publicity and implementation All units in all regions shall follow the notice of the state health and Health Commission and the State Administration of traditional Chinese medicine on printing and distributing the first batch of national key monitoring and rational drug use catalogue (chemical medicine and biological products) (Guo Wei ban Yi Han [2019] No 558), the notice of the General Office of the state health and Health Commission on doing a good job in the clinical application management of auxiliary drugs (Guo Wei ban Yi Han [2018] No 1112), and the provincial The notice of the health and Health Commission on the establishment of key drug monitoring system (gwyz [2017] No 105) and the notice of the provincial health and Health Commission Office on the adjustment of the first batch of provincial key drug monitoring directory in 2019 (gwbyyz [2019] No 10) and other four documents require that in 2019, the first batch of key monitoring and rational drug use directory in Jiangxi Province (hereinafter referred to as the monitoring directory), See the appendix) within 10 working days after printing and distributing, actively publicize the directory of drugs for rational use under key monitoring of the region and the unit to the public in the form of government affairs publicity, hospital affairs publicity, official website publicity, etc 2、 Responsibility of compaction subject The administrative departments of health and health at all levels shall implement the territorial management responsibility, regularly evaluate the implementation of the monitoring catalogue, timely admonish and talk with units and individuals with poor monitoring effect and poor policy implementation, timely supervise and inspect, and make rectification within a time limit All medical institutions shall implement the responsibility of monitoring subjects, include all varieties in the catalogue of drugs for rational use into the scope of prescription review, strictly implement the relevant requirements of prescription review, strengthen the training and education of rational use knowledge, and standardize the diagnosis and treatment behavior of doctors 3、 Strengthen internal and external supervision All localities and units should further strengthen the information disclosure, establish and improve the system of government affairs disclosure and hospital affairs disclosure, and actively accept the supervision of all sectors of society All kinds of medical institutions at all levels shall, on the basis of implementing prescription comments, publicize the departments and doctors with large amount of drugs, large amount of money and inappropriate rate of drugs in the hospital OA system and hospital affairs open column on a regular basis every month Our committee will also regularly supervise and inspect the implementation of the work, and timely report Appendix: list of the first batch of key monitoring rational drugs in Jiangxi Province in 2019.doc list of the first batch of key monitoring rational drugs in Jiangxi Province in 2019